REDUCE LAP-HF II Analyses Show 50% of Study Patients Demonstra...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEWKSBURY, Mass., April 1, 2022 /PRNewswire-AsiaNet/ -- Landmark trial advances understanding of which HFpEF patients may benefit from atrial shunt therapyCorvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), announced publication of analyses from its globa...
Authors: LATEST ASIANET NEWS RELEASES